Key Takeaways Merit Medical won CE Mark approval for Embosphere in knee osteoarthritis treatment.The approval expands Embosphere's use into a large, underserved patient population.Clinical results show sustained pain reduction and improved function with Embosphere.Merit Medical Systems (MMSI) has secured a major regulatory milestone with the CE Mark approval of its Embosphere Microspheres for genicular artery embolisation (GAE) to treat knee osteoarthritis (OA). This expanded indication marks a significant ...

Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results.SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolisation (GAE) to treat patients with knee osteoarthritis (OA). The most common type of arthritis, OA aff ...